You are here: Industry Insights > Drug

News List

Cystic fibrosis: Company urged to lower cost of life-changing drug firstwordpharma
April 24, 2018
Health ministers in the UK have urged Vertex Pharmaceuticals to drop the price of its cystic fibrosis drug Orkambi for NHS patients, reported BBC News.
Bluebird Bio One Step Closer to its First Approved Drug biospace
April 23, 2018
Bluebird bio, headquartered in Cambridge, Massachusetts, announced interim data from two different two-year clinical trials of LentiGlobin gene therapy for transfusion-dependent beta-thalassemia (TDT).
Diabetes drug may not reduce risk of death europeanpharmaceuticalreview
April 19, 2018
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings…
Alnylam hopes for 2018 filing for RNAi liver disease drug pharmaphorum
April 17, 2018
The technology uses small strands of RNA to silence or interfere with the coding of rogue proteins that cause certain diseases – but ..
Suit Alleges Drug Impurity, Price Fixing as Mallinckrodt Shares Tumble biospace
April 16, 2018
Amid news of a whistleblower lawsuit, Mallinckrodt Pharmaceuticals (MNK:NYSE) shares dropped 9.51% yesterday.
Pfizer announces trial success for rare cardiac disease drug pharmaceutical-technology
April 09, 2018
Pfizer has announced positive results from its Phase III study of experimental drug tafamidis in patients with transthyretin cardiomyopathy.
Two-drug combination proves effective for most lung cancers europeanpharmaceuticalreview
April 08, 2018
New study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
With Cash in Hand, Novartis Could Seek Deal to Bolster Drug Pipeline biospace
March 29, 2018
The sale of the consumer health product business is a signal that the company intends to focus its resources on drug development. But what could that look like
Study Reveals Huge Potential for mRNA Drug Targets biospace
March 20, 2018
Companies that have a strong focus on developing drugs that target messenger RNA (mRNA) may be ahead of the curve when it comes to potentially tapping into a lucrative market space.
Researchers use novel methods to determine drug uptake for tumours europeanpharmaceuticalreview
March 15, 2018
Researchers at the Moffitt Cancer Center in Florida have combined single-cell imaging of cancer cells in mice with mathematical modelling to establish which drug characteristics determine its efficacy.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page